/
Nephrology
221Diseases↗
1.8KPipeline Programs↗
842Active Trials↗
Momentum Score:100/100
Landscape
Disease Coverage Map
Bubble size = actively recruiting trials · Click to explore
Analysis
Phase Distribution
Analysis
Trial Status
4,113
clinical trials
Completed2,254 · 55%
Unknown status478 · 12%
Recruiting447 · 11%
Terminated365 · 9%
Not yet recruiting237 · 6%
Withdrawn156 · 4%
Other176 · 4%
Competitive
Top Companies Companies ranked by number of pipeline programs they run in this therapeutic area.
Landscape
Diseases
Chronic Kidney Disease
Most programs448
Programs
121
Trials
81
Recruiting
Pre
93
P1
59
P2
146
P3
124
Appr
135
Most programs:
AstraZeneca
AstraZenecaKidney Disease
Most trials219
Programs
192
Trials
17
Recruiting
Pre
25
P1
52
P2
50
P3
40
Appr
82
Most programs:
Novartis
NovartisNephropathy
Highest activity106
Programs
99
Trials
9
Recruiting
Pre
24
P1
6
P2
32
P3
33
Appr
37
Most programs:Novartis
NovartisAcute Kidney Injury
3146 programs48 trialsApproved
Lupus Nephritis
5113 programs44 trialsApproved
Diabetic Nephropathy
1109 programs9 trialsApproved
Renal Insufficiency
104 programs8 trialsApproved
Iga Nephropathy
175 programs34 trialsApproved
Membranous Nephropathy
154 programs30 trialsApproved
Nephrotic Syndrome
256 programs21 trialsApproved
CKD
10 programs60 trialsPhase 3
Renal Colic
47 programs9 trialsApproved
Focal Segmental Glomerulosclerosis
247 programs7 trialsApproved
Autosomal Dominant Polycystic Kidney Disease
39 programs9 trialsApproved
Kidney Failure
40 programs4 trialsApproved
Polycystic Kidney Disease
17 programs15 trialsApproved
Glomerulonephritis
21 programs7 trialsApproved
Chronic Renal Failure Syndrome
25 programs0 trialsApproved
Nephrolithiasis
222 programs2 trialsApproved
Hepatorenal Syndrome
21 programs1 trialApproved
IGA Glomerulonephritis
21 programs0 trialsApproved
Alport Syndrome
16 programs5 trialsApproved
Primary Membranous Nephropathy
0 programs21 trialsPhase 3
Renal Impairment
10 programs19 trialsPhase 1
Renal Disease
0 programs18 trials
Stage 5 Chronic Kidney Disease
16 programs0 trialsApproved
Glomerular Disease
111 programs5 trialsPhase 2/Phase 3
Cystic Kidney Disease
0 programs15 trials
Idiopathic Nephrotic Syndrome
11 programs1 trialApproved
Immunoglobulin a Nephropathy
0 programs12 trialsPhase 3
Showing top 30 diseases by activity. 191 more diseases in this therapeutic area.Activity = a momentum score from recent trial starts, number of sponsoring companies, and total trial volume.
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)